
Home » CARDIOME/ASTELLAS: FDA SETBACK FOR HEART DRUG
CARDIOME/ASTELLAS: FDA SETBACK FOR HEART DRUG
June 2, 2006
The FDA has refused to accept an application for a proposed treatment of atrial fibrillation. The approval of Cardiome's new treatment for atrial fibrillation is set to be delayed by almost a year after the FDA refused to file an application for the drug.
Pharmaceutical Business Review
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr